Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Gross Profit Margin (Quarterly): 76.98% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 76.98% |
| June 30, 2024 | 74.03% |
| March 31, 2024 | 74.24% |
| December 31, 2023 | 64.03% |
| September 30, 2023 | 78.57% |
| June 30, 2023 | 81.83% |
| Date | Value |
|---|---|
| March 31, 2023 | 84.24% |
| December 31, 2022 | 83.90% |
| September 30, 2022 | 84.39% |
| June 30, 2022 | 85.56% |
| March 31, 2022 | 81.20% |
| December 31, 2021 | 39.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
39.36%
Minimum
Dec 2021
85.56%
Maximum
Jun 2022
75.69%
Average
79.88%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 87.70% |
| Cytokinetics Inc | -18.17K% |
| Amicus Therapeutics Inc | 90.62% |
| MannKind Corp | 74.28% |
| TG Therapeutics Inc | 88.86% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.13% |
| Return on Assets | -15.22% |
| Return on Invested Capital | -18.16% |
| Profit Margin (Quarterly) | -15.75% |
| Operating Margin (Quarterly) | -14.03% |
| Return on Net Operating Assets | -29.02% |